Biggest fallers were only 5%. The first of these was AJB:AJ Bell
which I only bought on Friday but it dropped afterwards and there's also
spread. Not a great start to my latest magic formula share.
SBTX:SkinBioTherapeutics also fell 5% in my SIPP for no reason other
than drift because nothing seems to be happening.
I don't usually mention rises of less than 5%, but
PLUS:Plus500 climbed 4% and is now in profit by 2%. I have so few
things in profit I figured it was worth celebrating. It's only £24 up, but
I've also had £47 in dividends. I'm past my 12 month review period, but as
it still appears in my top 30 magic formula shares using the new ranking
system, I've clocked on the review date by 12 months.
CEY:Centamin climbed by 6% but is still 31% down. This is another
magic formula share that's past the 12 month review date but still in the
top 30, so again I've clocked on the review date another year.
TLOU:Tlou Energy went up 7%. It may have been caused by photos of
the breaking ground ceremony for the electricity transmission lines. This
demonstrates that they really are going ahead with the project and when
it's finished there should be a huge amount of revenue. For now they are
still 47% down.
JLP:Jubilee Metals had the biggest rise this week of 9%, but I'm
not giving it Share of the Week because it's 9% of my purchase price which
is a much smaller percentage rise of the current price. I'm still going to
measure percentage change based on my purchase price though, as keeping a
snapshot of last week's price to measure the rise is too much effort.
IGG:IG Group climbed 8% after really good results, but they are
still 12% down from when I bought them. They are also still in my top 30
magic formula shares, so their review date has also clocked on 12 months.
Share of the week is CAML:Central Asia Metals because they climbed
8% to go back into profit, and it's just after I doubled the size of my
holding so I'm very happy with them. Although they are in my top 30 magic
formula ranking, I'm not going to treat them as a magic formula share as I
like them too much. I'll keep adding more and build my holding back up to
what it was a few years ago.
Managed to stay just above the injection line.
Hopefully just a little dip as people take OPTI:Optibiotix trading profits.
Here's the ISA and shares portfolio after week 51 of year 7.
Cash is up £100 as I had none to pay fees so opened a new ISA for the tax year with £100. Potential profits up £54 thanks to JLP:Jubilee Metals, and £2,198 drop in value thanks to OPTI:Optibiotix. Next week marks the end of year 7 which will look better than it actually was thanks to the big share dividend when PBX:Probiotix was spun out.
As with the combined chart, we're just above the injection line
Looks a bit steeper than the dip on the combined chart.
| Weekly Change | |||
| Cash | £100 |
+£100 | |
| Portfolio cost | £82,912.77 | +£0 | |
| Portfolio sell value (bid price-commission) | £46,259.27 | (-44.2%) | -£2,198.34 |
| Potential profits | £1,217.55 | +£54.00 | |
| Yr 7 Dividends | £10,425.77 | +£0 | |
| Yr 7 Profit from sales | £3,970.12 | +£0 | |
| Yr 7 projected avg monthly profit | £1,219.68 | (33.0%) | -£24.39 |
| Total Dividends | £11,768.92 | +£0 | |
| Total Profit from sales | £28,094.06 | +£0 | |
| Average monthly cash profit |
£472.01 |
(12.8%) | -£1.31 |
|
(Sold stocks profit + Dividends - Fees / Months) |
|||
| Compound performance | 89% | +0% |
Cash is up £100 as I had none to pay fees so opened a new ISA for the tax year with £100. Potential profits up £54 thanks to JLP:Jubilee Metals, and £2,198 drop in value thanks to OPTI:Optibiotix. Next week marks the end of year 7 which will look better than it actually was thanks to the big share dividend when PBX:Probiotix was spun out.
As with the combined chart, we're just above the injection line
Looks a bit steeper than the dip on the combined chart.
The SIPP looks like this after week 347 overall and week 35 of year 7.
Potential profits are up £96, some of which was PLUS:Plus500 and some of which was CAML:Central Asia Metals. Much excitement with a 1p interest payment!
| Weekly Change | ||||
| Cash | £103.73 | +£28.06 | ||
| Portfolio cost | £98,389.93 | +£3.96 | ||
|
Portfolio sell value (bid price - commission) |
£57,907.77 | (-41.1%) | -£1,666.11 | |
| Potential profits | £86.08 | +£86.08 | ||
| Yr 7 Dividends | £10,727.13 | +£0 | ||
| Yr 7 Interest | £0.01 | +£0.01 | ||
| Yr 7 Profit from sales | £275.31 | +£32.00 | ||
| Yr 7 projected avg monthly profit | £1,346.85 | (28.9%) | -£35.58 | |
| Total Dividends | £13,931.52 | +£0 | ||
| Total Interest | £0.21 | +£0.01 | ||
| Total Profit from sales | £23,999.94 | +£32.00 | ||
| Average monthly cash profit | £461.87 | (9.9%) | -£0.94 | |
|
(Sold stocks profit + Dividends - Fees / Months) |
||||
| Compound performance | 66% | +0% |
Potential profits are up £96, some of which was PLUS:Plus500 and some of which was CAML:Central Asia Metals. Much excitement with a 1p interest payment!
I sold my shares in DNLM:Dunelm Group because they were outside the
top 30 magic formula shares using my new ranking method, so it was a
mistake to buy them a few weeks ago. Seeing as they popped into profit I
sold my 121 shares at 872.0062p making £32 (3.6%) profit.
As I mentioned in the intro, I re-invested in AJB:AJ Bell which is
in the top 30 magic formula shares and is also on an ascending trajectory,
as another rule for my magic formula shares is never to buy them if they
are on their way down. I've learnt from my mistakes with that one - on
many occasions! I bought 325 shares at 307.1359p costing £1,015.13 with
commission and stamp duty.
Total value dropped £1,666 but long term performance still looking good,
at least until DDDD:4D Pharma go bust at which point it will be
dreadful.
Same as the other charts
Slightly less steep drop than the ISA
The trading account looks like this after week 313 overall and week 1 of year 7.
We start year 7 this week so thankfully all the huge negatives from year 6 have gone back to zero. Potential profits went up by £13 thanks to JLP:Jubilee Metals so I'm hoping that means the big seller has stopped, as it was just typical that this should happen the week after I bought them for my trading account!
Still desperately bad
I like this chart more!
| Weekly Change | |||
| Cash | £43.18 | +£0 | |
| Portfolio cost | £1,877.84 | +£0 | |
| Portfolio sell value (bid price - commission) | £721.00 | (-61.6%) | +£13.92 |
| Potential profits | £0.00 | +£0 | |
| Year 7 Dividends | £0.00 | +£0 | |
| Year 7 Profit | £0.00 | +£0 | |
| Yr 7 projected avg monthly profit | £0.00 | (0.0%) | +£0 |
| Dividends | £60.10 | +£0 | |
| Profit from sales | £226.60 | +£0 | |
| Average monthly cash profit | £3.97 | (2.5%) | -£0.01 |
|
(Sold stocks profit + Dividends - Fees / Months) |
We start year 7 this week so thankfully all the huge negatives from year 6 have gone back to zero. Potential profits went up by £13 thanks to JLP:Jubilee Metals so I'm hoping that means the big seller has stopped, as it was just typical that this should happen the week after I bought them for my trading account!
Still desperately bad
I like this chart more!
There's a sense of excitement in the OPTI:Optibiotix camp like I've
not seen before. After 7 years of mostly misery it looks as if there will
be a run of big announcements through the rest of this year. I thought
Sweetbiotix was our holy grail, but it's looking like the microbiome
modulators could be even bigger. That's astonishing because Sweetbiotix is
going to be huge. It's been a long wait, but if everything pans out as
hoped, it will have been worth it.
No comments:
Post a Comment